DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

PEG-Intron (Peginterferon Alfa-2B) - Cardio-Respiratory Arrest - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Cardio-Respiratory Arrest ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include cardio-respiratory arrest. The selected reports were submitted to the FDA during the sample period of about a year.

Possible PEG-Intron side effects in 62 year old male

Reported by a physician from Japan on 2012-02-10

Patient: 62 year old male, weighing 76.0 kg (167.2 pounds)

Reactions: Brain Death, Confusional State, Prostatitis, Pulmonary Embolism, Pyrexia, Cardio-Respiratory Arrest, Malaise, Chest Pain, Pulmonary Artery Thrombosis, Decreased Appetite, Persecutory Delusion, Rash, Delirium, Aggression, Haemoglobin Decreased, Hypoxic-Ischaemic Encephalopathy, Visual Impairment, Venous Thrombosis, Blood Pressure Decreased, Cardiac Arrest, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MP-424 (Investigational Drug)
    Dosage: 2250 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2009-02-03
    End date: 2009-04-17

Ribavirin
    Dosage: 800 mg;qd;po 600 mg;qd;po 400 mg;qd;po 200 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2009-04-20
    End date: 2009-04-25

Ribavirin
    Dosage: 800 mg;qd;po 600 mg;qd;po 400 mg;qd;po 200 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2009-02-13
    End date: 2009-04-19

Ribavirin
    Dosage: 800 mg;qd;po 600 mg;qd;po 400 mg;qd;po 200 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2009-02-03
    End date: 2009-02-23

Ribavirin
    Dosage: 800 mg;qd;po 600 mg;qd;po 400 mg;qd;po 200 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2009-02-24
    End date: 2009-03-09

PEG-Intron
    Dosage: 120 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2009-02-03
    End date: 2009-04-22

Other drugs received by patient: Cefotiam Hydrochloride; Imipenem and Cilastatin Sodium; Lendormin D; Loxonin; Levofloxacin; Selbex; Harnal D; Cernilton (Cernitin Pollen Extract); Soldem 3A

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014